General procedure A -Ugi reaction
The isocyanide (1 equiv.) was added to the carboxylic acid (1 equiv.) , amine (1 equiv.) and paraformaldehyde (1.5 equiv.) in ethanol (4 mL mmol -1 ) and the resulting mixture was heated in the microwave (20 min, 100 °C). The volatiles were evaporated under reduced pressure and the residue purified by column chromatography (eluent 20-100% CH 2 Cl 2 / methanol / NH 3 (aq) -90:10:1 in CH 2 Cl 2 ).
General procedure B -Ester hydrolysis of Ugi products Sodium hydroxide (1.5 equiv.) in water (2 mL mmol -1 ) was added to a solution of the ethyl ester (1 equiv.) in methanol (5 mL mmol -1 ) and stirred for 12 h. Water (50 mL mmol -1 ) was added and washed with CH 2 Cl 2 (2 x 50 mL mmol -1 ). The aqueous layer was acidified to pH 1 with 1M HCl and extracted with CHCl 3 / isopropylalcohol (4:1) (3 x 50 mL mmol -1 ). Combined organics were dried over MgSO 4 , filtered and concentrated in vacuo to afford the desired acid. O-Benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate (HBTU) (1 equiv.) was added to a solution of carboxylic acid (1 equiv.) and triethylamine (2 equiv.) in DMF (50 mL mmol -1 ). The resulting mixture was stirred for 15 min before being added dropwise to a solution of amine (1 equiv.) and triethylamine (1 equiv.) in DMF (50 mL mmol -1 ). After stirring for 12 h the solvent was removed in vacuo. The residue was purified by flash column chromatography (eluent 0-15% methanol in CH 2 Cl 2 ) to afford the desired product.
General procedure C -Amide coupling of inhibitor and photoreactive scaffold
tert-Butyl (2-(2-(2-aminoethoxy) 
ethoxy)ethyl)carbamate, 1 13
Di-tert-butyldicarbonate (1.26 g, 5.78 mmol) in CHCl 3 (80 mL) was added dropwise to a solution of 2,2'-(ethylenedioxy)-bis-(ethylamine) (8.00 mL, 54.0 mmol) in CHCl 3 (80 mL) at 0 °C. The reaction was allowed to warm to room temperature and stirred overnight. The solvent was evaporated, water (80 mL) added and extracted with CH 2 Cl 2 (3 x 60 mL). Combined organics were dried over MgSO 4 , filtered and concentrated in vacuo to afford 13 as a colourless oil (1.42 g, 99%) ;  H (400 MHz, CDCl 3 ) 1.45 (9 H, s, C(CH 3 ) 3 ), 2.89 (2 H, t, J=5 .0 Hz, NH 2 CH 2 ), 3.32 (2 H, m, J=14.5 Hz, CH 2 NHBoc), 3.48-3.58 (4 H, m, 2 x 
tert-Butyl
(2-(2-(2-(5-((S,S,R)-2-oxohexahydro-1H-thieno [3,4-d] imidazol-4-yl)pentanamido) ethoxy)ethoxy)ethyl)carbamate, 1 14 HBTU (2.41 g, 6.36 mmol) was added to a solution of D-biotin (1.43 g, 6. 36 mmol) and diisopropylethyl amine (DIPEA, 1.15 mL, 6.94 mmol) in DMF (50 mL) and stirred for 20 min before being added dropwise to a solution of 13 (1.05 g, 4.24 mmol) in DMF (50 mL). The reaction mixture was stirred for 2 h at room temperature after which time the solvent was removed in vacuo. Purification by flash column chromatography (eluent CH 2 Cl 2 / methanol, 95:5) afforded 14 (1.62 g, 81%) as a colourless gum;  H (400 MHz, CD 3 OD) 1.32- 1.53 (11 H, m, C(CH 3 ) 3 , SCHCH 2 CH 2 ), 1.54-1.84 (4 H, m, SCHCH 2 CH 2 CH 2 ), 2.23 (2 H, t, J=7 .0 Hz, NC(O)CH 2 ), 2.72 (1 H, d, J=12 . 5 Hz, SCHH), 2.94 (1 H, dd, J=12.5, 4 .0 Hz, SCHH), 3.23 (3 H, t, J=5.5 Hz, SCH) , m, NCH 2 3.48-3.59 (4 H, m, 2 x NCH 2 CH 2 O), 3.62 (4 H, s, OCH 2 CH 2 O), 4.31-4.35 (1 H, m, NC(O) NHCH), 4.50-4.54 (1 H, m, CHNHC(O) N- ethoxy)ethyl) -5-((S,S,R)-2-oxohexahydro-1H-thieno[3,4-d] imidazol-4yl)pentanamide, 1 
F
Trifluoroacetic acid (5 mL) was added to a solution of 14 (2.11g, 4.45 mmol) in CH 2 Cl 2 (25 mL) and the resulting mixture was stirred overnight. The solvent was removed in vacuo and "azeotroped" with CH 2 Cl 2 (3 x 25 mL). The resulting trifluoroacetic acid salt was dissolved in methanol and loaded onto an strong cation exchange chromatography column (TELOS® SCX SPE tube) eluting with methanol (5 column volumes) followed by methanol / NH 3 (aq) 9:1 (5 column volumes). The basic eluent was concentrated in vacuo to afford F as a colourless gum (1.37 g, 80%);  H (400 MHz, CD 3 OD) 1.46 (2 H, q, J=7.5 Hz, SCHCH 2 
2-
Triethylamine (36 µL, 0.26 mmol) was added to a solution of lissamine rhodamine B sulfonyl chloride (100 mg, 0.18 mmol) in CHCl 3 (5 mL 4, 113.5, 113.6, 125.7, 126.5, 130.6, 132.7, 133.0, 141.4, 148.0, 155.0, 155.6, 157.1, 157.5 (aromatic and carbonyl carbons) ; HRMS (ESI + ) C 35 1, 115.3, 127.7, 129.3, 132.6, 133.6, 135.5, 143.9, 147.3, 157.2, 157.8, 159.4 
tert-Butyl 4-(3-(trifluoromethyl)diaziridin-3-yl)benzoate 19 (565 mg, 1.96 mmol) and triethylamine (0.80 mL, 5.88 mmol) were added to CH 2 Cl 2 (10 mL). Iodine (1.50 g, 5.88 mmol) was added portionwise until a brown colour persisted. The resulting mixture was stirred for 2 h and then washed with 1M aqueous NaOH (10 mL), water (10 mL) and brine (10 mL 
Trifluoroacetic acid (0.50 mL) was added to a solution of tert-butyl 4-(3-(trifluoromethyl)-3H-diazirin-3yl)benzoate, 48, (524 mg, 1.83 mmol) in CH 2 Cl 2 (5 mL). The reaction mixture was stirred for 2 h before the solvent was removed in vacuo and the residual trifluoroacetic acid azeotroped with CH 2 Cl 2 (3 x 25 mL). CH 2 Cl 2 (25 mL) and sat. aqueous NaHCO 3 (25 mL) were added. The layers were separated and the aqueous layer acidified to pH 3 with 1M aqueous HCl and extracted with CH 2 Cl 2 (3 x 25 mL Sodium azide (0.65 g, 10.0 mmol) was added to a solution of methyl pentafluorobenzoate (1.50 g, 6.64 mmol) in acetone (12 mL) and water (4 mL). The reaction mixture was heated at reflux for 2 h and then cooled to room temperature before addition of water (30 mL) and diethyl ether (30 mL). The layers were separated and the aqueous layer extracted with diethyl ether (2 x (6 mL) and heated at reflux for 18 h. The reaction mixture was cooled to room temperature and the solvent removed in vacuo to afford the crude N- (3-((tert-butoxycarbonyl) amino)propyl)formimidate as a pale yellow oil, which was used directly in the next step. Phosphoryl trichloride (0.59 mL, 6.35 mmol) in tetrahydrofuran (5 mL) was added dropwise over 30 min to the crude ethyl N- (3-((tert-butoxycarbonyl) (1 H, dd, J=12.5, 4.5 Hz, SCHH), (1 H (1 H, dd, J=7.5, 4.5 Hz, SCHRCH), 4.50 (1 H, dd, J=7.5, 5. 1, 49.9, 51.5, 54.4 (OCH 2 CH 2 NRR', 2 rotamers, NRR'CH 2 C(O)N, 2 rotamers), 57.0 (SCHRR'), 61.6 (SCH 2 C), 62.4 (CH 2 CH 3 ), 63.4 (SCHRC), 69. 2, 69.9, 70.7, 71.3, 71 .4 (CH 2 OCH 2 CH 2 OCH 2 , extra signals as a result of rotamers), 123.5 (q, J=273.0 Hz, CF 3 ), 127. 8, 128.0, 128.8, 129.3, 131.4, 131.7, 138.7, 138.8 (6 x C(Ar) , extra signals as a result of rotamers), 166.1 (NC(O)N), 171. 2, 171.4, 171.5, 173.6, 173.8, 176.2 (4 x [3,4-d] imidazol-4-yl) -9,12-dioxa-3,6,15-triazaicosan-1-oate, 6d According to general procedure A: 3-(3-methyl-3H-diazirin-3-yl)propanoic acid, E, (67.8 mg, 0.53 mmol), ethyl 2-isocyanoacetate (97 µL, 0.53 mmol), paraformaldehyde (24 mg, 0.80 mmol) and F (200 mg, 0.53 mmol) were reacted to afford 6d (208 mg, 63%) as a colourless gum;  max (thin film) 3304 (N-H), 2928 (C-H), 1746 (C=O, ester), 1697, 1636 (C=O, amides, urea) (1 H, dd, J=8.0, 4.5 Hz, SCHRCH) 6.88 -8.72 (13 H, m, 13 x C(Ar)H).  C (126 MHz, CD 3 OD) 12.8 (CH 2 CH 3 ), 28.1, 29.6 (CH 2 CH 2 CH 2 , 2 rotamers), 41.5, 42.0 (CH 2 CH 2 CH 2 , 2 rotamers), 41.9 (NCH 2 C(O)), 46.0 (CH 2 CH 2 CH 2 ), 46.8 (CH 2 CH 3 ), 54.8 (NCH 2 C(O)), 97.0, 115. 1, 115.3, 119.9, 120.3, 127.8, 129.5, 130.0, 132.6, 133.8, 135.5, 143.3, 143.7, 146.0, 147.3, 157.2, 157.9, 159.4 (aromatic carbons), 169.5, 171.3, 171.8, 173.9, 174.2 (3 x C=O, 2 rotamers Production of PHD2181-426.
Human PHD2181-426 (termed PHD2 throughout) was produced in E. coli BL21(DE3) and purified by cation exchange and size exclusion chromatography, as described. 7 Apo-PHD2 was obtained, after cation exchange chromatography, by incubation with EDTA.
KD determinations by NMR
Solvent water relaxation experiments were conducted using a Bruker Avance II 500 MHz spectrometer equipped with a 5 mm inverse 1 H/ 19 F( 13 C) TXI probe. All experiments were conducted at 298 K. 3 mm MATCH tubes (Bruker) were used and the sample volume was 160 μL.
Samples contained 50 μM apo-PHD2 181-426 , 50 μM MnCl 2 , 125 mM NaCl, 0.02% NaN 3 and 50 mM Tris-D11 (pH 7.5) dissolved in 12.5% H 2 O and 87.5% D 2 O. The titratant stock solutions of probes 1-5 (25 mM) were prepared in DMSO / DMSO-D6, which was then titrated directly into the NMR tube (typically 0.2 μL to 0.5 μL per addition) using a 1 μL plunger-in-needle syringe (SGE) . Changes in the bulk water relaxation rate (1-R 1 /R 1(0) , in which R 1 is the longitudinal relaxation rate of the bulk water in the presence of ligands and R 1(0) is the longitudinal relaxation rate of the bulk water in the absence of ligands) was plotted against the titrated ligand concentrations to obtain K D 's ( Figure S1 ).
Experimental procedures were carried out as described. 8 
Protein Electrospray Ionization Mass Spectrometry
Intact protein masses were recorded by liquid chromatography / mass spectrometry (LC/MS) using a 6530QTof (Agilent) single quadrupole mass spectrometer, interfaced with a Agilent 1100 liquid chromatography and sample handling system. The protein sample (5 µM, 5 µL) The eluent was injected directly into the mass spectrometer. The following MS parameters were used: Vcap 3500; Desolvation temperature -350 o C; Drying gas flow -10 l.hour -1 ; Desolvation gas flow (N 2 ) -20 l.hour -1 . Data acquisition was done in 2GHz standard high gain mode.
Sodium formate was used to calibrate the instrument. Spectra were processed using Mass Hunter Qualitative analysis ™ B06.00 (Agilent) with the Maximum Entropy method (MaxEnt1) employed.
PHD2 crosslinking time-course
PHD2 (5 µM), MnCl 2 (10 µM) and probe (at twice K D ) in Tris buffer (50 mM Tris, 100 mM NaCl [pH 7.5]) were incubated at room temperature for 20 min before being irradiated (310 nm or 350 nm, 4 °C) for the required time using a CaproBox TM . Irradiation times longer than 5 min were carried out in 5 min pulses separated by 1 min intervals to prevent sample warming. Samples were analysed by liquid chromatographymass spectrometry. Percentage crosslinking was calculated from the ratio of the heights of the modified and unmodified protein peaks in the deconvoluted mass spectrum and plotted against time (Figure 3 (310 nm) , Figure S2 (350 nm) ). Tables reporting the intensities of modified and unmodified PHD2 peaks in the deconvoluted mass spectra obtained after irradiation (310 nm) of PHD2 in the presence of Mn II and probes 1-5 (Table  S1- 5) . The heights of the 20 most intense peaks in the range 25000 to 30000 Da were extracted and all others masses assigned a height of zero. Peaks corresponding to crosslinked protein were not observed without irradiation, at T = 0. 
Time-course of PHD2 crosslinking at 350 nm
Tables reporting the intensities of modified and unmodified PHD2 peaks in the deconvoluted mass spectra obtained after irradiation (350 nm) of PHD2 in the presence of Mn II and probes 1-5 (Table  S6- 10) . The heights of the 20 most intense peaks in the range 25000 to 30000 Da were extracted and all others masses assigned a height of zero. Peaks corresponding to crosslinked protein were not observed without irradiation, at T = 0. 
PHD2 crosslinking controls
Tables reporting the intensities of modified and unmodified PHD2 peaks in the deconvoluted mass spectra obtained after irradiation (310 nm, 20 min) of PHD2-Mn II in the presence either probes 1-5 with 200 µM IOX1 (Table S11 ) or scaffolds 6a-e (Table S12 ). The heights of the 20 most intense peaks in the range 25000 to 30000 Da were extracted and all others masses assigned a height of zero. No crosslinking was observed. Mass spectrometric analysis of rate of probe activation and resulting products Mass spectrometric analysis of probes after irradiation (310 nm, 0.5, 2.5 and 10 min) indicates that the rate of activation of the probes increases in the order 4 < 1 < 3 < 2 ( Figure S3 ). The rate of activation of 5 is unknown since intramolecular reactions and reaction with water afford the same mass as the parent compound. The masses of the species formed when activated probe molecules do not react with PHD2 gives an indication of the mechanisms of quenching. Probe 1 primarily reacts to give a species with a mass that corresponds to loss of N 2 , which likely arises from intramolecular insertion of the nitrene into a C-H or X-H bond. The major peak in the mass spectrum of probe 2 after 10 min irradiation has a mass of 2 -N 2 + H 2 , which may arise from reduction of the formed nitrene to give the amine. Probe 3 gives predominantly a species resulting from reaction of the carbene with H 2 O, while in contrast, diazirine 4 appears to give exclusively a species resulting from intramolecular insertion of the carbene, likely αC-H insertion to give the alkene. 9 Figure S3 . Mass spectrometric analysis of probes 1-5 after 0.5, 2.5 and 10 min irradiation (310 nm) in the presence of PHD2 and Mn 2+ . Speactra for compound 1 are in the absence of PHD2 since 1 could not be detected in the presence of PHD2.
Limited trypsin digests and MALDI MS 10
PHD2 (20 µM), Mn II (20 µM) and probe (50 µM) in 15 mM NH4OAc (pH 7.5) were incubated at room temperature for 20 min before irradiation (310 nm, 12 min, 4 °C). Sequence grade modified trypsin (trypsin / PHD2 1:200 w/w) was added and the digest mixture incubated at room temperature (1 h) and then 37 °C (2 h). At regular intervals over a 3 h period, 2 µL samples were removed and quenched by addition of 4 µL quenching buffer (H 2 O / methanol / HCO 2 H, 90:10:0.1). 1 µL sample was mixed with 1 µL sinapinic acid (SA) or α-cyano-4-hydroxycinnamic acid (CHCA) matrix (both Laser BioLabs) and pippetted onto a 96 spot MALDI target. Spots were allowed to air dry and analysed using a MALDI micro MX mass spectrometer (Waters) in linear positive ion mode with laser energy 220, pulse voltage 1250 V, detector voltage 2750 V and mass suppression 1000 Da. Data were analysed using MassLynx v4.0. Spectra were smoothed using the mean method (smooth windows = 200; number of smooths = 2).
Trypsin digests and LC-MS/MS
PHD2 (20 µM), MnCl 2 (20 µM) and probe (50 µM) in Tris buffer (50 mM Tris, 100 mM NaCl [pH 7.5]) were incubated at room temperature for 20 min before being irradiated (310 nm, 12 min, 4 °C). The protein was subjected to reductive acetylation and trypsin digest according to standard procedures. 11
The analysis of digested material was performed by LC-MS/MS using a Waters Q-Tof Premier mass spectrometer (Waters) coupled to a nano-UPLC system (NanoAcquity, Waters) using a reversed phase 75 µm x 250 mm column as previously described. 11 Table S13 . 
Crystal structure analysis
The binding mode of probes 1-5 was modelled by manual docking of the selectivity function (derived from IOX1) with PHD2. Docking was guided by crystal structures of PHD2 in complex with a bidentate isoquinoline inhibitor {[(4-hydroxy-8-iodoisoquinolin-3-yl)carbonyl]amino}acetic acid (PDB ID: 2G1M), and the structurally related 2-oxoglutarate dependent histone demethylase KDM4A in complex with 4-carboxy-8-hydroxyquinoline (PDB ID: 4BIS) (Figure S5) . 
